Intellectual Property

Bacterial glycoprotein antigens for vaccine development

Intellectual Property

The intellectual property behind GlyProVac ApS includes:

The YghJ antigen

EP3359559A1: GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC), Pending


US20180282379A1: Glycosylated yghj polypeptides from enterotoxigenic escherichia coli (etec), Pending


The BEMAP method

US 10,647,749 B2: GLYCOSYLATED YGHJ POLYPEPTIDES FROM ENTEROTOXIGENIC ESCHERICHIA COLI (ETEC), Granted (Date of patent May 12th 2020)





Copyright © All Rights Reserved